1-7 of 7
Horst Muller
Close
Sort by
Journal Articles

Correlation between Progression-Free Survival and Overall Survival in Patients with Relapsed Hodgkin Lymphoma: An Analysis of Individual Patient Data from Randomized GHSG Trials

Paul J Bröckelmann, Horst Müller, Sarah Gillessen, Anne Sophie Jacob, Jesko Momotow, Carla Damaschin, Justin Ferdinandus, Xiaoqin Yang, Michael Fuchs, Carsten Kobe, Hans Theodor Eich, Andreas Engert, Peter Borchmann, Bastian von Tresckow
Journal: Blood
Blood (2023) 142 (Supplement 1): 3070.
https://doi.org/10.1182/blood-2023-188622
Published: 2023
Journal Articles

Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Peter Herhaus, Julia Meissner, Karolin Trautmann-Grill, Horst Müller, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4456.
https://doi.org/10.1182/blood-2023-189250
Published: 2023
Journal Articles

Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Peter Herhaus, Julia Meissner, Karolin Trautmann-Grill, Horst Müller, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1710.
https://doi.org/10.1182/blood-2023-188734
Published: 2023
Journal Articles

Throly Score Successfully Classifies Hodgkin Lymphoma Patients at Risk of Thromboembolic Complication

Darko Antic, Vladimir Otasevic, Sven Borchmann, Horst Muller, Vojin Vukovic, Vladislava Djurasinovic, Kristina Tomic, Biljana Mihaljevic, Grigoris Gerotziafas, MD PhD, Andreas Engert, MD, Jawed Fareed, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-141367
Published: 2020
Journal Articles

Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment

Sven Borchmann, MD, Ida Hude, MD, Horst Müller, PhD, Heinz Haverkamp, Carolin Bürkle, MD, Michael Fuchs, MD, Peter Borchmann, MD, Andreas Engert, MD
Journal: Blood
Blood (2016) 128 (22): 4151.
https://doi.org/10.1182/blood.V128.22.4151.4151
Published: 2016
Journal Articles

Seasonal Differences in Incidence and Survival of Hodgkin Lymphoma Depend on Geographic Location of Diagnosis

Sven Borchmann, MD, Horst Müller, PhD, Andreas Engert, MD
Journal: Blood
Blood (2016) 128 (22): 2996.
https://doi.org/10.1182/blood.V128.22.2996.2996
Published: 2016
Journal Articles

Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL)

Paul J Bröckelmann, MD, Horst Müller, PhD, Olivier Casasnovas, MD, Martin Hutchings, MD, Bastian von Tresckow, MD, Peter Borchmann, MD, Craig Moskowitz, MD, Andreas Engert, MD
Journal: Blood
Blood (2015) 126 (23): 1978.
https://doi.org/10.1182/blood.V126.23.1978.1978
Published: 2015